
Daniel E. Kolker
Supervisory Patent Examiner (ID: 12246, Phone: (571)272-3181 , Office: P/1644 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1645, 1649, 1644, 1646 |
| Total Applications | 545 |
| Issued Applications | 178 |
| Pending Applications | 76 |
| Abandoned Applications | 291 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7185011
[patent_doc_number] => 20050191711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto'
[patent_app_type] => utility
[patent_app_number] => 11/024223
[patent_app_country] => US
[patent_app_date] => 2004-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7877
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191711.pdf
[firstpage_image] =>[orig_patent_app_number] => 11024223
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/024223 | Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto | Dec 28, 2004 | Abandoned |
Array
(
[id] => 7136744
[patent_doc_number] => 20050181478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/025607
[patent_app_country] => US
[patent_app_date] => 2004-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 251
[patent_figures_cnt] => 251
[patent_no_of_words] => 275330
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181478.pdf
[firstpage_image] =>[orig_patent_app_number] => 11025607
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/025607 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 27, 2004 | Abandoned |
Array
(
[id] => 5107003
[patent_doc_number] => 20070065881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Isolated cytotoxic factor associated with multiple sclerosis and method of detecting said cytotoxic factor'
[patent_app_type] => utility
[patent_app_number] => 10/582674
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13543
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065881.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582674
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582674 | Method of isolating cytotoxic heterocomplex associated with multiple sclerosis | Dec 21, 2004 | Issued |
Array
(
[id] => 7004589
[patent_doc_number] => 20050169902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers'
[patent_app_type] => utility
[patent_app_number] => 11/012849
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16223
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169902.pdf
[firstpage_image] =>[orig_patent_app_number] => 11012849
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/012849 | Methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers | Dec 14, 2004 | Issued |
Array
(
[id] => 5842245
[patent_doc_number] => 20060121039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration'
[patent_app_type] => utility
[patent_app_number] => 11/006161
[patent_app_country] => US
[patent_app_date] => 2004-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4688
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121039.pdf
[firstpage_image] =>[orig_patent_app_number] => 11006161
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/006161 | Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration | Dec 6, 2004 | Abandoned |
Array
(
[id] => 5715136
[patent_doc_number] => 20060078499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Use of hedgehog agonist to treat depression'
[patent_app_type] => utility
[patent_app_number] => 11/002769
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16319
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20060078499.pdf
[firstpage_image] =>[orig_patent_app_number] => 11002769
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/002769 | Use of hedgehog agonist to treat depression | Nov 30, 2004 | Abandoned |
Array
(
[id] => 5225015
[patent_doc_number] => 20070254281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Specific Marker Lmx1a on Dopaminergic Neurons'
[patent_app_type] => utility
[patent_app_number] => 10/580989
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19333
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254281.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580989
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580989 | Specific marker Lmx1a on dopaminergic neurons | Nov 25, 2004 | Issued |
Array
(
[id] => 7098437
[patent_doc_number] => 20050130896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Methods and compostions for inhibiting intracellular aggregate formation'
[patent_app_type] => utility
[patent_app_number] => 10/991197
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 22841
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991197
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991197 | Methods for identifying modulators of intracellular aggregate formation | Nov 16, 2004 | Issued |
Array
(
[id] => 8164458
[patent_doc_number] => 08173591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Variants of pigment epithelium derived factor and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/718873
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 14352
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173591.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718873 | Variants of pigment epithelium derived factor and uses thereof | Nov 15, 2004 | Issued |
Array
(
[id] => 7163971
[patent_doc_number] => 20050085629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Utilization of FPRL1 as a functional receptor by serum amyloid A (SAA)'
[patent_app_type] => utility
[patent_app_number] => 10/987664
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21234
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20050085629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987664
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987664 | Utilization of FPRL1 as a functional receptor by serum amyloid A (SAA) | Nov 11, 2004 | Abandoned |
Array
(
[id] => 159040
[patent_doc_number] => 07674599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-09
[patent_title] => 'Methods of using antibodies to detect alpha-synuclein in fluid samples'
[patent_app_type] => utility
[patent_app_number] => 10/984192
[patent_app_country] => US
[patent_app_date] => 2004-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 12383
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/674/07674599.pdf
[firstpage_image] =>[orig_patent_app_number] => 10984192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/984192 | Methods of using antibodies to detect alpha-synuclein in fluid samples | Nov 7, 2004 | Issued |
Array
(
[id] => 7136722
[patent_doc_number] => 20050181466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Immunosorbent blood tests for assessing paroxysmal cerebral discharges'
[patent_app_type] => utility
[patent_app_number] => 10/983845
[patent_app_country] => US
[patent_app_date] => 2004-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10949
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181466.pdf
[firstpage_image] =>[orig_patent_app_number] => 10983845
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/983845 | Immunosorbent blood tests for assessing paroxysmal cerebral discharges | Nov 7, 2004 | Issued |
Array
(
[id] => 7255869
[patent_doc_number] => 20050143287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 10/977113
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12174
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143287.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977113
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977113 | Primate prokineticin receptor polypeptides | Oct 28, 2004 | Issued |
Array
(
[id] => 5638034
[patent_doc_number] => 20060069008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Treatment of neurological deficits in the striatum or substanta nigra pars compacta'
[patent_app_type] => utility
[patent_app_number] => 10/952064
[patent_app_country] => US
[patent_app_date] => 2004-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5972
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10952064
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/952064 | Treatment of neurological deficits in the striatum or substanta nigra pars compacta | Sep 27, 2004 | Abandoned |
Array
(
[id] => 5638035
[patent_doc_number] => 20060069009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Treatment of neurological deficits in the striatum or substanta nigra pars compacta'
[patent_app_type] => utility
[patent_app_number] => 10/952065
[patent_app_country] => US
[patent_app_date] => 2004-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5054
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069009.pdf
[firstpage_image] =>[orig_patent_app_number] => 10952065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/952065 | Treatment of neurological deficits in the striatum or substanta nigra pars compacta | Sep 27, 2004 | Abandoned |
Array
(
[id] => 4657127
[patent_doc_number] => 20080025988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Monoclonal Antibody And Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/589969
[patent_app_country] => US
[patent_app_date] => 2004-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8013
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20080025988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10589969
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/589969 | Monoclonal antibodies and use thereof | Sep 15, 2004 | Issued |
Array
(
[id] => 5204548
[patent_doc_number] => 20070026029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Apheresis device'
[patent_app_type] => utility
[patent_app_number] => 10/571469
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7883
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026029.pdf
[firstpage_image] =>[orig_patent_app_number] => 10571469
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/571469 | Methods of treating Alzheimer's Disease with an apheresis device | Sep 12, 2004 | Issued |
Array
(
[id] => 7225539
[patent_doc_number] => 20050255122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => utility
[patent_app_number] => 10/934818
[patent_app_country] => US
[patent_app_date] => 2004-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26203
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255122.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934818
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934818 | Prevention and treatment of amyloidogenic disease | Sep 1, 2004 | Abandoned |
Array
(
[id] => 7082669
[patent_doc_number] => 20050048049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => utility
[patent_app_number] => 10/923474
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 32271
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923474 | Prevention and treatment of amyloidogenic disease | Aug 19, 2004 | Abandoned |
Array
(
[id] => 7045132
[patent_doc_number] => 20050249727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => utility
[patent_app_number] => 10/923605
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 32286
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249727.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923605
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923605 | Prevention and treatment of amyloidogenic disease | Aug 19, 2004 | Abandoned |